openPR Logo
Press release

Impact of COVID-19 on the US Ventilator Industry Market Size, Trends and Forecast To 2025

04-21-2020 10:24 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

The US is the leader in the global medical device industry. As per the International Trade Administration, the US generated a revenue of $156 billion in 2017, which accounted for 40% of the global medical device industry. The US medical device companies are renowned globally owing to their high technology and innovative products. Even though the country has a significant share in medical device, it is currently facing a shortage of essential medical equipment amid COVID-19 outbreak. The coronavirus cases in the US surpassed 100,000 and thereby healthcare facilities have been reported an increasing need for more medical equipment to provide better care to the COVID-19 patients. Among medical equipment, there is a remarkable demand for ventilators to provide breathing support to the COVID-19 patients, as the major symptom of the condition is breathing problem.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/impact-of-covid-19-on-the-us-ventilator-industry

The US government is working closely to meet the demand for ventilators and asked ventilator manufacturers to expand their ventilators production capacity. In March 2020, the US Food and Drug Administration (FDA) has taken action to support enhance the ventilators supply, ventilator accessories, ventilator tubing connectors, as well as filtering facepiece respirators (FFRs) due to COVID-19. The US FDA issued an Emergency Use Authorization (EUA) for supporting the emergency use of certain ventilators, positive pressure breathing devices, and anesthesia gas machines modified for use as ventilators in health care settings, anesthesia gas machines modified for use as ventilators.

A Full Report of Impact of COVID-19 on the US Ventilator Industry Market is Available at: https://www.omrglobal.com/industry-reports/impact-of-covid-19-on-the-us-ventilator-industry

The EUA demonstrated the FDA's ability to adapt and react faster during the epidemic by offering higher flexibility in regulations and enabling to raise the inventory for the US ventilator. This, in turn, will allow patients with COVID-19 to have access to lifesaving devices which is urgently required. On 25th March 2020, Prisma Health received EUA from the US FDA for its VESper ventilator expansion device. This device will enable to increase the capacity of the ventilator for COVID-19 patients.

The study on the effect of COVID-19 on the US ventilator industry is segmented into portable and intensive care ventilators. Portable ventilators are being significantly adopted for the treatment of respiratory conditions. Portable ventilators are normally utilized by patients who require breathing support for the long-term. These are compact and lightweight and provides certain similar features that earlier was available only on expensive intensive care ventilators. Several companies are working towards increasing production of portable ventilators, as per the government orders. For instance, on 24th March 2020, ZOLL Medical Corp. declared that it is taking aggressive steps to expand the production capacity to 10,000 ventilators every month amid COVID-19 epidemic.

The major companies supplying ventilators to the US for the treatment of patients with COVID-19 include General Electric Co., ZOLL Medical Corp., Ford Motors Co., Ventec Life Systems, Inc., ResMed Corp., and Hill-Rom Holdings, Inc. These companies are partnering to expand their production limit of ventilators to cope up with the continuously increasing demand.

Industry Overview

Historical market growth estimation in the US ventilator industry excluding COVID-19 pandemic effect
Deviations in the US ventilator industry growth rate due to COVID-19 pandemic

Segmentation

By Type

Portable
Intensive Care

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/impact-of-covid-19-on-the-us-ventilator-industry

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Impact of COVID-19 on the US Ventilator Industry Market Size, Trends and Forecast To 2025 here

News-ID: 2018218 • Views:

More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for FDA

DreaMed receives 5th FDA Clearance
TEL AVIV, Israel: DreaMed Diabetes LTD. ("DreaMed" or the "Company"), developer of the endo.digital Clinical Decision Support System announced today that it has received its 5th U.S Food and Drug Administration (FDA) clearance that expands the scope of AI enhanced treatment recommendations to patients on fixed meal insulin regimens. endo.digital is the first decision support system that has been cleared to assist healthcare providers in the management of diabetes
FDA Compliant Blood Storage and Preservation
Accsense Monitoring System Automates Data Archive and Alarming CAS DataLoggers provided the temperature alarming and monitoring system to a hospital blood bank looking to replace their old paper chart recorders as they became unreliable and spare parts were harder to find. For proper blood storage and preservation, the lab’s medical units needed to maintain storage temperatures between 2°C to 6°C (36°F to 43°F), given the perishability of blood components. The facility
FDA grants orphan drug status to Vicore
US Food and Drug Administration has awarded Vicore Pharmaceuticals with orphan Drug designation for the treatment of Idiopathic Pulmonary Fibrosis (IPF). FDA’s Orphan Drug Designation program provides certain incentives for companies developing therapeutics to treat rare diseases or conditions, defined as those affecting less than 200,000 individuals in the U.S. A drug candidate and its sponsor must meet several key criteria in order to qualify for, and obtain, orphan drug
New FDA Design Control Training Courses
Salt Lake City, Utah - February 23 2017 - Procenius Consulting is a medical device consulting firm specializing solely in medical device design controls regulation (21 CFR 820.30). Announcing New Design Control Training Courses Procenius Consulting has just launched two new training courses covering basic and advanced topics of medical device design control regulation. These courses focus on compliance, practical implementation and industry best practices techniques for developing or improving a
fda online training
GRC Training Solutions provides end-to-end FDA compliance solutions for those companies who want to maximize security, minimize operational costs, improve staff productivity and stay on top of all their compliance documentation. GRC Training Solutions boasts a team of experts and specialists who have a proven track record in working with the biotechnology, medical device, diagnostic and pharmaceutical fields. Our team will work with you closely and develop solutions that meet
11-09-2016 | Science & Education
GRCTS
FDA online training
Description: Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. Initially, FDA issued a 28-page Proposed Rule that would amend its regulations regarding